Mallinckrodt (MNK) Warns of Chapter 11 Filing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- US stock futures dip as oil breaches $100 mark for the first time since mid-year
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Mallinckrodt plc (MNK) PT Lowered to $2 at BMO Capital
August 4, 2020 12:50 PM EDTBMO Capital analyst Gary Nachman lowered the price target on Mallinckrodt plc (NYSE: MNK) to $2.00 (from $4.00) while maintaining a Market Perform rating.
The analyst commented, "2Q results overall were better than previously lowered expectations given COVID-19 and other pressures, but focus... More
Mallinckrodt (MNK) Tops Q2 EPS by 54c, Revenues Beat
August 4, 2020 6:09 AM EDTMallinckrodt (NYSE: MNK) reported Q2 EPS of $1.89, $0.54 better than the analyst estimate of $1.35. Revenue for the quarter came in at $700.9 million versus the consensus estimate of $635.33 million.
Second quarter net sales of $166.5 million net of the retrospective one-time Acthar® Gel Medicaid liability; adjusted net sales of $700.9 million, a decline of 14.9%, due primarily to demand impacts related to COVID-19 and competitive and payer pressures on certain productsDiluted loss per share of $11.04 with adjusted diluted earnings per share (EPS) of $1.89, a decline of 25.3%Operating cash flows of $170.9 million in the... More